Ines Pineda-Torra

Education

PhD in Pharmaceutical Sciences Univ. of Lille/Pasteur Institute of Lille/France 2001 Research Year Erasmus University of Utrecht, The Netherlands 1996 BSc in Chemistry (5 year degree, esp. in Biochemistry) Universidad Complutense de Madrid 1995

Recent Google Scholar Publications

1. Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study
   Journal of the American Heart Association 14 (8), e036507 , 2025, 2025 | Citations: 7.0
2. Dysregulated Lipid Metabolism Networks Modulate T-cell Function in People with Relapsing Remitting Multiple Sclerosis
   Clinical and Experimental Immunology, uxae032 , 2024, 2024 | Citations: 16.0
3. Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity
   iScience , 2024, 2024 | Citations: 23.0
4. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk
   Rheumatology, kead646 , 2023, 2023 | Citations: 20.0
5. Insulin resistance in macrophages impacts cholesterol biosynthesis and interferon gene expression and reduces foam cell formation capacity
   Endocrine Abstracts 94 , 2023, 2023

Links

• ORCID https://orcid.org/0000-0002-7349-2208
• Google Scholar https://scholar.google.com/citations?user=NaCOKUMAAAAJ
• Scopus https://www.scopus.com/authid/detail.uri?authorId=None
• Personal Weblink https://www.cabimer.es/en/research-groups/metabolism-immunology-and-cardiovascular-risk/